Evidence map›Paper›PMID 30273927›Full record

ReviewCells, tissues, organs2018

Oxygen Regulation in Development: Lessons from Embryogenesis towards Tissue Engineering.

Shahrzad Fathollahipour, Pritam S Patil, Nic D Leipzig

Abstract readReview
In one paragraph

Review in Cells, tissues, organs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Article
  3. Ultra-low oxygen tension duringbioRxiv : the preprint server for biology · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. βMedicinal research reviews · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. β-Adrenoceptors in Cancer: Old Players and New Perspectives.Handbook of experimental pharmacology · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shahrzad FathollahipourDepartment of Chemical and Biomolecular Engineering, University of Akron, Akron, Ohio, USA.
Pritam S PatilDepartment of Chemical and Biomolecular Engineering, University of Akron, Akron, Ohio, USA.
Nic D LeipzigDepartment of Chemical and Biomolecular Engineering, University of Akron, Akron, Ohio, USAnl21@uakron.edu.
University of Akron · US

Funding

OXAID: Oxygenating Hydrogel for Diabetic Wound CareR41DK105704 · NIDDK · O2 REGENTECH, LLC · PI INMANN, ANDREAS, LEIPZIG, NIC D · 2016 to 2016
$225k
NIDDK NIH HHS R41 DK105704
6 · The paper itself

Abstract

Oxygen is a vital source of energy necessary to sustain and complete embryonic development. Not only is oxygen the driving force for many cellular functions and metabolism, but it is also involved in regulating stem cell fate, morphogenesis, and organogenesis. Low oxygen levels are the naturally preferred microenvironment for most processes during early development and mainly drive proliferation. Later on, more oxygen and also nutrients are needed for organogenesis and morphogenesis. Therefore, it is critical to maintain oxygen levels within a narrow range as required during development. Modulating oxygen tensions is performed via oxygen homeostasis mainly through the function of hypoxia-inducible factors. Through the function of these factors, oxygen levels are sensed and regulated in different tissues, starting from their embryonic state to adult development. To be able to mimic this process in a tissue engineering setting, it is important to understand the role and levels of oxygen in each developmental stage, from embryonic stem cell differentiation to organogenesis and morphogenesis. Taking lessons from native tissue microenvironments, researchers have explored approaches to control oxygen tensions such as hemoglobin-based, perfluorocarbon-based, and oxygen-generating biomaterials, within synthetic tissue engineering scaffolds and organoids, with the aim of overcoming insufficient or nonuniform oxygen levels and nutrient supply.

Indexed as

Embryonic DevelopmentTissue EngineeringAnimalsCell DifferentiationCell HypoxiaEmbryonic Stem CellsHumansMorphogenesisOrganogenesisOxygenOxygenEmbryonic developmentHypoxiaMorphogenesisOrganoidsOxygen bioavailabilityOxygen deliveryTissue engineering

Identifiers

PMID30273927
PMCPMC6397050
OpenAlexW2895698434

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.